Topics

Ethris Company Profile

10:15 EST 21st January 2020 | BioPortfolio

Ethris is paving a new path from genes to therapeutic proteins using our proprietary messenger RNA technology. Developed in-house, our integrated platform enables the discovery, design and development of transcript therapies that restore missing functions in patients’ cells and tissues. We will advance transcript therapies to transform the treatment of disease independently and with our partners. For more information, visit www.ethris.com.


News Articles [5 Associated News Articles listed on BioPortfolio]

Ethris Announces Expansion of Leadership Team

Thomas Langenickel, M.D. appointed to Chief Medical Officer as lead program ETH42 advances toward clinical trials Ethris GmbH, a leader in mRNA-based therapeutics with specifi...

Ethris and Munster University Hospital Receive ZIM Grant for Rare Pulmonary Disease Research

Collaboration with Prof. Heymut Omran’s laboratory aimed at studying the impact of Ethris’ therapeutic mRNA strategy on primary ciliary dyskinesia Ethris GmbH, a leader in mRNA-based therapeutic...

Global mRNA Vaccines Therapeutics Market Research Report 20122024 [Published by HeyReport] Prices from USD $2240

SummaryThe global mRNA Vaccines Therapeutics market will reach xxx Million USD in 2019 with CAGR xx% 20192024. The objective of report is to define, segment, and project the market on the basis of pr...

Global mRNA Vaccines Therapeutics Market Research Report 20122024 [Report Updated: 22052019] Prices from USD $2240

SummaryThe global mRNA Vaccines Therapeutics market will reach xxx Million USD in 2019 with CAGR xx% 20192024. The objective of report is to define, segment, and project the market on the basis of pr...

Global mRNA Vaccines Therapeutics Market Research Report 20122024 [Report Updated: 22052019] Prices from USD $1904

SummaryThe global mRNA Vaccines Therapeutics market will reach xxx Million USD in 2019 with CAGR xx% 20192024. The objective of report is to define, segment, and project the market on the basis of pr...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

Ethris GmbH

Ethris is paving a new path from genes to therapeutic proteins using its proprietary messenger RNA technology platform, which enables the discovery, design and development of tran...

Ethris

Ethris is paving a new path from genes to therapeutic proteins using our proprietary messenger RNA technology. Developed in-house, our integrated platform enables the discovery, d...

More Information about "Ethris" on BioPortfolio

We have published hundreds of Ethris news stories on BioPortfolio along with dozens of Ethris Clinical Trials and PubMed Articles about Ethris for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Ethris Companies in our database. You can also find out about relevant Ethris Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks



Searches Linking to this Company Record